Molecular Pathology & Genomics

Artificial enzymes programmed to destroy SARS-CoV-2

Cambridge scientists have used synthetic biology to create artificial enzymes programmed to target the genetic code of SARS-CoV-2 and destroy the virus.

Education, development and knowledge acquisition

It’s not about winning, it’s about the journey and what we learn along the path of that journey that really matters, writes Dr Guy Orchard.

Biopsy, diagnostics and tumour removal

Researchers from Japan may have devised a way to perform the initial biopsy, lab tests, and subsequent tumour removal during one surgical procedure.

Cell-free DNA cancer detection

A US-led research team has reported successful results from an experimental cell-free DNA (cfDNA) cancer-detection system that is claimed to be cost effective.

Recent advances in biomedical science

Deputy Editor Andrew Blann summarises some articles recently published in the British Journal of Biomedical Science.

Car t-cell therapy

The immunotherapy tool that ushered in a new era in cancer treatment options.

Nanopore sequencing for rare genetic disorders

Using nanopore sequencing investigators can accurately detect specific genomic disorders in a fraction of the time it takes to conduct traditional and molecular cytogenetic testing.

My lab: encouraging and supporting research

Professor Stephen Fôn Hughes gives a guided tour of his laboratory in Wrexham, North Wales.

Characteristics of stable vitiligo skin disease

A new study reveals the unique cell-to-cell communication networks that can perpetuate inflammation and prevent repigmentation in patients with vitiligo disease.

Early disease detection using DNA droplets

A group of scientists has developed a computational DNA droplet with the ability to recognise specific combinations of chemically synthesised microRNAs (miRNAs) that act as biomarkers of tumours.

Top